Abstract
The serum concentrations of cis(Z)-flupentixol after injection of 2% and 10% cis(Z)-flupentixol decanoate in Viscoleo® (Depixol® injection, Fluanxol® Depot) have been investigated in a crossover study with eight schizophrenic patients. No statistically significant difference was found between the two preparations when the data from individual days or areas under the serum concentration curves were considered. For the individual patients a difference was found between the two treatments in six cases; one preparation gave the higher serum concentration in four cases and the other preparation in two cases. Thus, the difference found within individual patients reflects the intraindividual variation rather than a difference between preparations. The maximum serum concentration was seen at 4 or 7 days after injection. The maximum/minimum fluctuation ratio indicates that dosage intervals longer than 2 weeks seem reasonable for most of the patients. The similarity in the serum concentrations, no matter which concentration of flupentixol decanoate solution was given, indicates that a disperasal and possibly a metabolic breakdown of the oil depot takes place in the muscle.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Astrup, C., Grimsgard, A., Hebnes, K., Kruse-Jensen, A., Lid, M.: A study of flupenthixol decanoate and pipothiazine undecylenate in schizophrenics. Acta Psychiatr. Scand. 50, 481–491 (1974)
Bjerke, K., Faurby, A., Kirk, L.: Et års klinisk erfaring med Flupenthixol-dekanoat 10% (Lu 7105) i høj dosering. Nord. Psyk. Tidsskr. 26, 363 (1972)
Carney, M. W. P., Sheffield, B. F.: The long-term maintenance treatment of schizophrenic out-patients with depot flupenthixol. Curr. Med. Res. Op 1, 423–426 (1973)
Engstrand, E.: Klinisk undersøkelse av flupenthixol dekanoat 10% (Lu 7105). Nord. Psyk. Tidsskr. 28, 539–545 (1974)
Gottfries, C. G.: Klinisk prövning av flupenthixol decanoat som depå-neuroleptikum. Nord. Psykiatr. Tidsskr. 25, 296–303 (1971)
Gottfries, C. G., Green, L.: Flupenthixol decanoate in treatment of outpatients. Acta Psychiatr. Scand. (Suppl.) 255, 15–24 (1974)
Gross, H., Kaltenbäck, E.: Klinische Erfahrungen mit Flupenthixol-Decanoat (Fluanxol-Depot®) bei chronischen Psychosen. Wien. Klin. Wochenschr. 84, 80–84 (1972)
Jørgensen, A., Gottfries, C. G.: Pharmacokinetic studies on flupenthixol and flupenthixol decanoate in man using tritium labelled compounds. Psychopharmacologia 27, 1–10 (1972)
Jørgensen, A.: A sensitive and specific radioimmunoassay for cis(Z)-flupenthixol in human serum. Life Sci. 23, 1533–1542 (1978)
Wadzisz, D. F. J.: The clinical use of Depixol Concentrate in chronic schizophrenia. Paper read at Begian/Dutch Symposium on Depot Thioxanthenes, Copenhagen, Denmark. October 4, 1977
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Stauning, J.A., Kirk, L. & Jørgensen, A. Comparison of serum levels after intramuscular injections of 2% and 10% cis(Z)-flupentixol decanoate in Viscoleo® to schizophrenic patients. Psychopharmacology 65, 69–72 (1979). https://doi.org/10.1007/BF00491981
Received:
Issue Date:
DOI: https://doi.org/10.1007/BF00491981